Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Elea (Argentina)
h-index: 18
Total citations: 1,072
Total papers: 48
Homepage:
http://www.eleaint.com/
Recent papers from Elea (Argentina)
Soil Microbial Diversity and Network Organization Respond to Land Use and Agricultural Inputs Worldwide
Global Change Biology · 2026
Immune Response and Safety of Anti‐NeuGcGM3 Anti‐Idiotype Vaccine Racotumomab in Patients With High‐Risk Neuroblastoma: An Open‐Label, Single‐Arm, Multicenter Phase 2 Study in Argentina
Pediatric Blood & Cancer · 2026
New regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trial
BMJ Open · 2025
In Silico and In Vitro Evaluation of Bevacizumab Biosimilar MB02 as an Antitumor Agent in Canine Mammary Carcinoma
Animals · 2023
Preclinical Efficacy and Toxicology Evaluation of RAC1 Inhibitor 1A-116 in Human Glioblastoma Models
Cancers · 2022
Intensive Safety Monitoring of Rituximab (Biosimilar Novex® and the Innovator) in Pediatric Patients With Complex Diseases
Frontiers in Pharmacology · 2022
Effect of Ivermectin and Atorvastatin on Nuclear Localization of Importin Alpha and Drug Target Expression Profiling in Host Cells from Nasopharyngeal Swabs of SARS-CoV-2- Positive Patients
Viruses · 2021
Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial
EClinicalMedicine · 2021
Current State and Comparison of the Clinical Development of Bevacizumab, Rituximab and Trastuzumab Biosimilars
Future Oncology · 2021
Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials
Frontiers in Pharmacology · 2021
Safety and Pharmacokinetic Assessments of a Novel Ivermectin Nasal Spray Formulation in a Pig Model
Journal of Pharmaceutical Sciences · 2021
Ivermectin repurposing for COVID-19 therapy: Safety and pharmacokinetic assessment of a novel nasal spray formulation in a pig model
2020
Safety and clinical effectiveness of intravitreal administration of bevacizumab (Lumiere®) in patients with neovascular age‑related macular degeneration
Experimental and Therapeutic Medicine · 2020
Optimizing CIGB-300 intralesional delivery in locally advanced cervical cancer
British Journal of Cancer · 2015
Sensitivity of tumor cells towards CIGB‐300 anticancer peptide relies on its nucleolar localization
Journal of Peptide Science · 2012
Anti-idiotype antibodies in cancer treatment: the pharmaceutical industry perspective
Frontiers in Oncology · 2012
Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides – preclinical and clinical data
Frontiers in Oncology · 2012
NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines
Journal of Immunology Research · 2010
Safety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies
BMC Cancer · 2009
Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity
Molecular Cancer Therapeutics · 2009